CYP21A2 and congenital adrenal hyperplasia: EDS-related clinical manifestations were evaluated in all 21 patients with CAH-X and in some of their relatives carrying the continuous deletion involving the CYP21A2 and part of the TNXB gene (Table 2, Table 3 and Table 4).